Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7 | 5769 | 34.7 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
396 | 3 | SYSTEMIC LUPUS ERYTHEMATOSUS//ANTIPHOSPHOLIPID SYNDROME//LUPUS | 30351 |
1766 | 2 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT | 6417 |
7 | 1 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT | 5769 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTIPHOSPHOLIPID SYNDROME | authKW | 4527648 | 24% | 62% | 1380 |
2 | ANTIPHOSPHOLIPID ANTIBODIES | authKW | 3978322 | 21% | 63% | 1196 |
3 | LUPUS ANTICOAGULANT | authKW | 2904576 | 13% | 73% | 752 |
4 | ANTICARDIOLIPIN ANTIBODIES | authKW | 2605312 | 13% | 66% | 746 |
5 | BETA2 GLYCOPROTEIN I | authKW | 982193 | 4% | 86% | 215 |
6 | BETA 2 GLYCOPROTEIN I | authKW | 751505 | 3% | 86% | 166 |
7 | ANTI BETA2 GLYCOPROTEIN I ANTIBODIES | authKW | 659514 | 2% | 90% | 139 |
8 | ANTICARDIOLIPIN | authKW | 471286 | 2% | 64% | 140 |
9 | CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME | authKW | 463880 | 2% | 85% | 103 |
10 | LUPUS | journal | 300255 | 8% | 12% | 461 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 107682 | 25% | 1% | 1436 |
2 | Hematology | 24548 | 20% | 0% | 1173 |
3 | Peripheral Vascular Diseases | 10859 | 13% | 0% | 766 |
4 | Immunology | 3585 | 14% | 0% | 779 |
5 | Reproductive Biology | 2717 | 5% | 0% | 264 |
6 | Medicine, General & Internal | 2523 | 11% | 0% | 642 |
7 | Obstetrics & Gynecology | 2284 | 7% | 0% | 390 |
8 | Medical Laboratory Technology | 1126 | 3% | 0% | 148 |
9 | Pathology | 265 | 3% | 0% | 152 |
10 | Allergy | 175 | 1% | 0% | 59 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUPUS UNIT | 211744 | 2% | 35% | 116 |
2 | AUTOIMMUNE DIS | 120953 | 2% | 16% | 141 |
3 | BARBARA VOLCKER WOMEN RHEUMAT DIS | 120383 | 1% | 71% | 32 |
4 | ANTIPHOSPHOLIPID STANDARDIZAT | 106060 | 0% | 95% | 21 |
5 | CELL CHEM | 71367 | 1% | 30% | 45 |
6 | ALLERGY CLIN IMMUNOL RHEUMATOL UNIT | 60452 | 0% | 57% | 20 |
7 | SERV MALALTIES AUTOIMMUNES | 53353 | 0% | 39% | 26 |
8 | CLIN MED DERMATOL | 40996 | 0% | 29% | 27 |
9 | LOUISE COOTE LUPUS UNIT | 39039 | 0% | 31% | 24 |
10 | RAYNE | 35291 | 2% | 6% | 121 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUPUS | 300255 | 8% | 12% | 461 |
2 | AUTOIMMUNITY REVIEWS | 27048 | 2% | 6% | 93 |
3 | THROMBOSIS AND HAEMOSTASIS | 22929 | 4% | 2% | 209 |
4 | AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 18096 | 2% | 3% | 101 |
5 | THROMBOSIS RESEARCH | 17255 | 3% | 2% | 184 |
6 | JOURNAL OF RHEUMATOLOGY | 13967 | 3% | 1% | 185 |
7 | JOURNAL OF AUTOIMMUNITY | 11851 | 1% | 3% | 75 |
8 | CURRENT RHEUMATOLOGY REPORTS | 11493 | 1% | 7% | 32 |
9 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 10266 | 1% | 3% | 72 |
10 | CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 8807 | 1% | 4% | 41 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OZTURK, MA , HAZNEDAROGLU, IC , TURGUT, M , GOKER, H , (2004) CURRENT DEBATES IN ANTIPHOSPHOLIPID SYNDROME: THE ACQUIRED ANTIBODY-MEDIATED THROMBOPHILIA.CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. VOL. 10. ISSUE 2. P. 89-126 | 325 | 90% | 8 |
2 | MIYAKIS, S , LOCKSHIN, MD , ATSUMI, T , BRANCH, DW , BREY, RL , CERVERA, R , DERKSEN, RHWM , DE GROOT, PG , KOIKE, T , MERONI, PL , ET AL (2006) INTERNATIONAL CONSENSUS STATEMENT ON AN UPDATE OF THE CLASSIFICATION CRITERIA FOR DEFINITE ANTIPHOSPHOLIPID SYNDROME (APS).JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 4. ISSUE 2. P. 295-306 | 97 | 79% | 2196 |
3 | VLACHOYIANNOPOULOS, PG , SAMARKOS, M , SIKARA, M , TSILIGROS, P , (2007) ANTIPHOSPHOLIPID ANTIBODIES: LABORATORY AND PATHOGENETIC ASPECTS.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 44. ISSUE 3. P. 271-338 | 254 | 79% | 17 |
4 | MCINTYRE, JA , WAGENKNECHT, DR , FAULK, WP , (2003) ANTIPHOSPHOLIPID ANTIBODIES: DISCOVERY, DEFINITIONS, DETECTION AND DISEASE.PROGRESS IN LIPID RESEARCH. VOL. 42. ISSUE 3. P. 176 -237 | 232 | 78% | 34 |
5 | ISLAM, MA , ALAM, F , SASONGKO, TH , GAN, SH , (2016) ANTIPHOSPHOLIPID ANTIBODY-MEDIATED THROMBOTIC MECHANISMS IN ANTIPHOSPHOLIPID SYNDROME: TOWARDS PATHOPHYSIOLOGY-BASED TREATMENT.CURRENT PHARMACEUTICAL DESIGN. VOL. 22. ISSUE 28. P. 4451 -4469 | 174 | 77% | 0 |
6 | WILLIS, R , HARRIS, EN , PIERANGELI, SS , (2012) PATHOGENESIS OF THE ANTIPHOSPHOLIPID SYNDROME.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 38. ISSUE 4. P. 305 -321 | 141 | 88% | 31 |
7 | BERTOLACCINI, ML , AMENGUAL, O , ANDREOLI, L , ATSUMI, T , CHIGHIZOLA, CB , FORASTIERO, R , DE GROOT, P , LAKOS, G , LAMBERT, M , MERONI, P , ET AL (2014) 14TH INTERNATIONAL CONGRESS ON ANTIPHOSPHOLIPID ANTIBODIES TASK FORCE. REPORT ON ANTIPHOSPHOLIPID SYNDROME LABORATORY DIAGNOSTICS AND TRENDS.AUTOIMMUNITY REVIEWS. VOL. 13. ISSUE 9. P. 917 -930 | 100 | 93% | 39 |
8 | PIERANGELI, SS , CHEN, PP , RASCHI, E , SCURATI, S , GROSSI, C , BORGHI, MO , PALOMO, I , HARRIS, EN , MERONI, PL , (2008) ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID SYNDROME: PATHOGENIC MECHANISMS.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 34. ISSUE 3. P. 236-250 | 120 | 97% | 95 |
9 | MCNEIL, HP , CHESTERMAN, CN , KRILIS, SA , (1991) IMMUNOLOGY AND CLINICAL IMPORTANCE OF ANTIPHOSPHOLIPID ANTIBODIES.ADVANCES IN IMMUNOLOGY. VOL. 49. ISSUE . P. 193-280 | 188 | 82% | 425 |
10 | NAHASS, GT , (1997) ANTIPHOSPHOLIPID ANTIBODIES AND THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME.JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. VOL. 36. ISSUE 2. P. 149 -168 | 202 | 85% | 50 |
Classes with closest relation at Level 1 |